The anti-tumor character of GABPB1-AS1 was proposed in NSCLC, which was inconsistent with some former investigations of GABPB1-AS1 in other tumor types like glioma and osteosarcoma. This evidence concerns the gene GABPB1 and central nervous system cancer.